A detailed history of Velan Capital Investment Management LP transactions in Rezolute, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 800,000 shares of RZLT stock, worth $3.42 Million. This represents 8.03% of its overall portfolio holdings.

Number of Shares
800,000
Previous 800,000 -0.0%
Holding current value
$3.42 Million
Previous $3.44 Million 12.76%
% of portfolio
8.03%
Previous 8.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.29 - $5.79 $916,000 - $2.32 Million
400,000 Added 100.0%
800,000 $3.44 Million
Q1 2024

May 14, 2024

BUY
$0.95 - $2.55 $380,000 - $1.02 Million
400,000 New
400,000 $1.02 Million
Q2 2022

Aug 15, 2022

BUY
$2.6 - $3.85 $260,000 - $385,000
100,000 Added 33.33%
400,000 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$4.21 - $7.61 $1.26 Million - $2.28 Million
300,000 New
300,000 $1.43 Million

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $166M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.